Loading...

Valneva SE

INRLF•PNK
Healthcare
Biotechnology
$3.85
$0.60(18.46%)

Valneva SE (INRLF) Stock Overview

Explore Valneva SE’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap654.7M
P/E Ratio-6.27
EPS (TTM)$-0.65
ROE-0.43%
Fundamental Analysis

AI Price Forecasts

1 Week$3.25
1 Month$2.04
3 Months$3.31
1 Year Target$2.00

INRLF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Valneva SE (INRLF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 86.35, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $2.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.27 and a market capitalization of 654.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;